Refresher Course: Abdominal and Gastrointestinal
RC 2201 - Evaluation of liver metastases
Lectures
1
Chairperson's introduction
05:00Christoph Johannes Zech, Basel / CH
2
Assessing response to systemic therapy in liver metastases
15:00Federica Vernuccio, Palermo / IT
3
Imaging before and after locoregional treatment of liver metastases
15:00Monique Maas, Amsterdam / NL
4
Panel discussion: What are the main challenges of imaging in treatment planning and response assessment?
10:00Panel discussion: What are the main challenges of imaging in treatment planning and response assessment?
RC 2201-1
5 min
Chairperson's introduction
Christoph Johannes Zech, Basel / Switzerland
RC 2201-2
15 min
Assessing response to systemic therapy in liver metastases
Federica Vernuccio, Palermo / Italy
1. To summarise the role of CT and MRI for the assessment of response to systemic therapy in liver metastases.
2. To discuss established tumour response criteria and other morphological signs of response to systemic therapy in liver metastases.
3. To describe changes in the non-tumorous hepatic parenchyma after systemic therapy.
2. To discuss established tumour response criteria and other morphological signs of response to systemic therapy in liver metastases.
3. To describe changes in the non-tumorous hepatic parenchyma after systemic therapy.
RC 2201-3
15 min
Imaging before and after locoregional treatment of liver metastases
Monique Maas, Amsterdam / Netherlands
1. To know what to report in patients considered for locoregional treatment of liver metastases.
2. To know how to follow up with patients after liver ablations.
3. To identify normal and abnormal imaging findings after liver ablations.
2. To know how to follow up with patients after liver ablations.
3. To identify normal and abnormal imaging findings after liver ablations.
RC 2201-5
10 min
Panel discussion: What are the main challenges of imaging in treatment planning and response assessment?